Crescita Therapeutics Inc. (TSX:CTX)
Canada
· Delayed Price · Currency is CAD 0.5700
0.00 (0.00%)
Apr 24, 2025, 12:00 PM EDT
Crescita Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -2.75 | -1.99 | 0.86 | -1.11 | 0.04 | Upgrade
|
| Depreciation & Amortization | 1.37 | 1.51 | 1.47 | 1.38 | 1.49 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 1.92 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.05 | -0.02 | 0.06 | -0.01 | - | Upgrade
|
| Stock-Based Compensation | 0.18 | 0.08 | 0.22 | 0.27 | 0.16 | Upgrade
|
| Other Operating Activities | -0.01 | 0.68 | 0.08 | 0.61 | 0.43 | Upgrade
|
| Change in Accounts Receivable | 1.48 | 3.67 | -2.44 | -2.1 | 1.43 | Upgrade
|
| Change in Inventory | 2.17 | -0.92 | -1.78 | -1.38 | -0.04 | Upgrade
|
| Change in Accounts Payable | 0.43 | -1.22 | 0.23 | 0.99 | 0.33 | Upgrade
|
| Change in Other Net Operating Assets | -0.17 | 0.27 | 0.27 | -0.27 | -0.14 | Upgrade
|
| Operating Cash Flow | 2.73 | 2.08 | -1.02 | -1.6 | 5.61 | Upgrade
|
| Operating Cash Flow Growth | 31.26% | - | - | - | 5.69% | Upgrade
|
| Capital Expenditures | -2.1 | -0.13 | -0.23 | -0.35 | -0.06 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.08 | - | - | - | - | Upgrade
|
| Investment in Securities | - | - | -0.06 | - | - | Upgrade
|
| Other Investing Activities | - | - | - | -0.5 | - | Upgrade
|
| Investing Cash Flow | -2.02 | -0.13 | -0.29 | -0.85 | -0.06 | Upgrade
|
| Long-Term Debt Repaid | -0.44 | -0.41 | -1.37 | -0.35 | -0.36 | Upgrade
|
| Net Debt Issued (Repaid) | -0.44 | -0.41 | -1.37 | -0.35 | -0.36 | Upgrade
|
| Issuance of Common Stock | - | 0.02 | 0.01 | - | - | Upgrade
|
| Repurchase of Common Stock | -0.32 | -0.39 | -0.43 | -0.1 | -0.07 | Upgrade
|
| Other Financing Activities | -0.1 | - | -0.05 | -0.05 | -0.05 | Upgrade
|
| Financing Cash Flow | -0.86 | -0.78 | -1.85 | -0.5 | -0.48 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.04 | -0.01 | 0.06 | -0.01 | -0.06 | Upgrade
|
| Net Cash Flow | -0.11 | 1.15 | -3.09 | -2.95 | 5.01 | Upgrade
|
| Free Cash Flow | 0.63 | 1.94 | -1.25 | -1.94 | 5.55 | Upgrade
|
| Free Cash Flow Growth | -67.68% | - | - | - | 9.00% | Upgrade
|
| Free Cash Flow Margin | 3.21% | 11.09% | -5.31% | -11.59% | 35.48% | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.10 | -0.06 | -0.09 | 0.27 | Upgrade
|
| Cash Interest Paid | 0.05 | 0.06 | 0.11 | 0.16 | 0.15 | Upgrade
|
| Levered Free Cash Flow | 1.17 | 2.06 | -1.56 | -2.29 | 3.77 | Upgrade
|
| Unlevered Free Cash Flow | 1.21 | 2.11 | -1.46 | -2.14 | 3.92 | Upgrade
|
| Change in Net Working Capital | -3.69 | -1.88 | 3.25 | 2.51 | -1.82 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.